Compagnie Lombard Odier SCmA’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-481	Closed	-$82K	–	568
2018 Q3	$82K	Sell	481 -160	-25%	-$27.3K	﹤0.01%	371
2018 Q2	$83K	Buy	+641	New	+$83K	﹤0.01%	375